In patients with acute promyelocytic leukemia (APL), CP is expressed by bone marrow blasts at the onset of the disease and disappears at remission, while the expression of CP reflects the degree of malignant transformation, and its levels are influenced by treatment. Here, CP is linked to acute promyelocytic leukemia.